Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Coronavirus More Likely to Infect People with Blood Type A, Finds Study

By HospiMedica International staff writers
Posted on 23 Mar 2020
A new preliminary study in China has found that people having blood type A could be more vulnerable to the coronavirus, while those having type O blood might be more resistant. More...
According to researchers from the Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University (Wuhan, China) who studied COVID-19 in its outbreak epicenter, Wuhan, and the city of Shenzhen, the proportion of Type-A patients both infected and killed by the coronavirus was found to be “significantly” higher than those with the same blood type among the general public. On the other hand, Type O patients comprised a smaller proportion of those who were infected as well as killed by the coronavirus.

In their study, the researchers compared the blood types of 2,173 confirmed coronavirus patients in Wuhan and Shenzhen with over 3,694 healthy residents in the Wuhan area. According to the published research, 31.16% of the residents in Wuhan had Type-A blood, as against 37.75% of the surveyed coronavirus patients at the Wuhan Jinyintan Hospital having the same blood type. Out of these surveyed coronavirus patients, 25.8% had Type-O blood, as compared to 33.84% of the general population, while 25.8% had Type-O blood, as against 33.84% of the general population. An examination of 206 patients who had died from the coronavirus revealed that 85 victims, or 41.26%, had Type-A blood, while only 52 victims, or about a quarter, had Type-O blood.

“People of blood group A might need particularly strengthened personal protection to reduce the chance of infection,” according to the researchers, who however termed the study as preliminary and stated that more work was needed to confirm the findings.

Related Links:
Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.